| Genetic variation in CCL5 signaling genes and triple negative breast cancer: susceptibility and prognosis implications J Shan, A Chouchane, Y Mokrab, M Saad, S Boujassoum, RW Sayaman, ... Frontiers in oncology 9, 1328, 2019 | 20 | 2019 |
| Genetic predisposition to porto‐sinusoidal vascular disorder: A functional genomic‐based, multigenerational family study J Shan, A Megarbane, A Chouchane, D Karthik, R Temanni, AR Romero, ... Hepatology 77 (2), 501-511, 2023 | 11 | 2023 |
| Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms: Tips and pitfalls K Bräutigam, A Chouchane, B Konukiewitz, A Perren Pathologie (Heidelberg, Germany) 45 (1), 35-41, 2024 | 2 | 2024 |
| Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies SL April-Monn, K Detjen, P Kirchner, K Bräutigam, MA Trippel, IJ Marques, ... bioRxiv, 2022.12. 10.519855, 2022 | 2 | 2022 |
| Benign Metastasizing Leiomyoma: New insights into a rare disease with an obscure etiopathogenesis A Chouchane, S Boughizane, M Nouira, S Remadi Diagnostic pathology 19 (1), 2, 2024 | 1 | 2024 |
| Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies SL April-Monn, P Kirchner, K Detjen, K Bräutigam, MA Trippel, T Grob, ... NPJ precision oncology 8 (1), 59, 2024 | | 2024 |
| Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low-Grade Neoplasms: A Case with a Highly Increased Proliferation Rate A Chouchane, P Kirchner, I Marinoni, E Sticová, T Jirásek, A Perren Endocrine pathology, 1-7, 2024 | | 2024 |
| Praktische Anwendung von Immunhistochemie in pankreatischen neuroendokrinen Neoplasien K Bräutigam, A Chouchane, B Konukiewitz, A Perren Die Pathologie 45 (1), 35-41, 2024 | | 2024 |
